Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 3
2016 4
2017 11
2018 10
2019 8
2020 13
2021 18
2022 10
2023 4
2024 9
2025 8
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: in the last 1 year. Clear all
Page 1
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.
Giordano FA, Layer JP, Turiello R, Friker LL, Mirallas O, Pregler BEF, Potthoff AL, Zeyen T, Weller J, Sperk E, Sahm K, Oster C, Kebir S, Hambsch P, Schäfer N, Kadzik S, Renovanz M, Pietsch T, Bisdas S, Sepúlveda-Sánchez JM, Gómez-Puerto D, Vieito M, Platten M, Gkika E, Grauer OM, Tabatabai G, Schneider M, Glas M, Seidel C, Herrlinger U, Hölzel M. Giordano FA, et al. Among authors: renovanz m. Nat Commun. 2026 Apr 8;17(1):3405. doi: 10.1038/s41467-026-71362-7. Nat Commun. 2026. PMID: 41951573 Free PMC article. Clinical Trial.
Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis.
Asogwa OA, Dirven L, Aaronson NK, Baumert BG, van den Bent M, Brandes AA, Clement PM, Coens C, Chinot O, Gorlia T, Herrlinger U, Hertler C, Keime-Guibert F, Rhun EL, Lim L, Malmström A, Marosi C, Martinelli F, van der Meulen M, Oliver K, Pace A, Panciroli C, Reijneveld JC, Renovanz M, Roth P, Seidel C, Stupp R, Wick W, Weller M, Taphoorn MJB, Koekkoek JAF; EORTC Quality of Life Group and the EORTC Brain Tumor Group. Asogwa OA, et al. Among authors: renovanz m. Oncologist. 2026 Feb 5;31(3):oyag005. doi: 10.1093/oncolo/oyag005. Oncologist. 2026. PMID: 41572423 Free PMC article.
A Clinical Tool to Identify Incidental Meningioma for Early Outpatient Management.
Islim AI, Millward CP, Zakaria R, Piper RJ, Fountain DM, Mehta S, Kolamunnage-Dona R, Ali U, Koszdin SD, Georgious T, Mathew RK, Mills SJ, Brodbelt AR, Santarius T, Jenkinson MD; IMPACT Study Investigators, International Consortium on Meningioma (ICOM) and British Neurosurgical Trainee Research Collaborative (BNTRC). Islim AI, et al. JAMA Oncol. 2026 Jan 1;12(1):66-74. doi: 10.1001/jamaoncol.2025.4821. JAMA Oncol. 2026. PMID: 41264316
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma.
Landry AP, Wang JZ, Patil V, Ajisebutu A, Gui C, Yefet LS, Ellenbogen Y, Liu J, Mamatjan Y, Wei Q, Singh O, Mansouri S, Ehret F, Capper D, Cohen-Gadol AA, Tabatabai G, Tatagiba M, Behling F, Barnholtz-Sloan JS, Sloan AE, Chambless LB, Mansouri A, Makarenko S, Yip S, Tsang DS, Gao A, Aldape K, Nassiri F, Zadeh G; International Consortium On Meningiomas (ICOM)). Landry AP, et al. Neuro Oncol. 2026 Feb 1;28(2):430-439. doi: 10.1093/neuonc/noaf237. Neuro Oncol. 2026. PMID: 41259653 Free PMC article.
EANS-EANO guidelines on the extent of resection in gliomas.
Goldbrunner R, Foroglou N, Signorelli F, Schucht P, Jakola AS, Minniti G, Rola R, Renovanz M, Preusser M, Furtner J, Grossman R, Mawrin C, Demetriades A, Weller M, Simon M. Goldbrunner R, et al. Among authors: renovanz m. Neuro Oncol. 2026 Jan 1;28(1):38-54. doi: 10.1093/neuonc/noaf217. Neuro Oncol. 2026. PMID: 40973061
Physician-led versus questionnaire-based psychosocial screening in adults with high-grade glioma: a cluster-randomized controlled trial (GLIOPT).
Renovanz M, Hippler M, Kuchen R, Doerner L, Rieger D, Steinbach JP, Ronellenfitsch MW, Voss M, Kessler AF, Nickl V, Misch M, Onken JS, Rapp M, Nadji-Ohl M, Mehlitz M, Meixensberger J, Fehrenbach MK, Keric N, Ringel F, Coburger J, Lucas CW, Wehinger J, Schmidt-Graf F, Gempt J, Tatagiba M, Tabatabai G, Schranz M, Singer S. Renovanz M, et al. J Neurooncol. 2025 Dec;175(3):967-977. doi: 10.1007/s11060-025-05223-6. Epub 2025 Sep 10. J Neurooncol. 2025. PMID: 40931258 Free PMC article. Clinical Trial.
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N2M2 umbrella trial.
Wick W, Lanz LM, Wick A, Harting I, Dettmer S, Suwala AK, Ketter R, Tabatabai G, Seliger C, Glas M, Burger MC, Timmer M, Ringel FA, Mildenberger I, Schulz-Schaeffer WJ, Winkler F, König L, Herold-Mende C, Eisenmenger A, Pfister SM, Renovanz M, Bendszus M, Sahm F, Platten M, Kessler T. Wick W, et al. Among authors: renovanz m. Nat Med. 2025 Oct;31(10):3534-3541. doi: 10.1038/s41591-025-03928-9. Epub 2025 Sep 5. Nat Med. 2025. PMID: 40913172 Free PMC article. Clinical Trial.
Distress screening in patients with high-grade glioma: diagnostic accuracy in relation to a structured clinical interview in a multicenter cluster-randomized controlled trial.
Kuchen R, Singer S, Schranz M, Doerner L, Rieger D, Steinbach JP, Ronellenfitsch MW, Voss M, Kessler AF, Nickl V, Misch M, Onken JS, Rapp M, Nadji-Ohl M, Mehlitz M, Meixensberger J, Fehrenbach MK, Keric N, Ringel F, Coburger J, Lucas CW, Wehinger J, Schmidt-Graf F, Tatagiba M, Tabatabai G, Hippler M, Renovanz M. Kuchen R, et al. Among authors: renovanz m. Support Care Cancer. 2025 Jul 31;33(8):737. doi: 10.1007/s00520-025-09810-1. Support Care Cancer. 2025. PMID: 40745114 Free PMC article. Clinical Trial.
Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation.
Boele FW, Frances SM, Darlix A, Ducray F, Cartalat S, Guerdoux E, Tabouret E, Burger MC, Rydén I, Malmstrom A, Vauleon E, Kazda T, Renovanz M, Werner JM, Welsh L, Sanghera P, Dehais C, Desideri I, McBain C, Mehta S, Lord H, Jena R, Foweraker K, Ashkan K, Engelhardt J, Bourg V, Herrlinger U, Lawson McLean A, Hertler C, Haldbo-Classen L, Dahlrot RH, Noel G, Durando X, Hrab I, Razis E, Weller M, Muhic A, Klein M. Boele FW, et al. Among authors: renovanz m. Neuro Oncol. 2025 Nov 1;27(11):2959-2974. doi: 10.1093/neuonc/noaf172. Neuro Oncol. 2025. PMID: 40692477 Free PMC article.
11 results